Diffuse Alveolar Hemorrhage after Allogeneic Hematopoietic Stem-Cell Transplantation: Treatment with Recombinant Factor VIIa

Chest

Volumn 124, Issue 6, 2003, Pages 2400-2403

  Pastores, Stephen M ^a   Papadopoulos, Esperanza ^a   Voigt, Louis ^a   Halpern, Neil A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Diffuse alveolar hemorrhage; Recombinant factor VIIa

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; CARBOPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DIURETIC AGENT; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; RAPAMYCIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; THIOTEPA; VINCRISTINE; WARFARIN;

ADULT; ARTICLE; BLEEDING; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSE ALVEOLAR HEMORRHAGE; GRAFT VERSUS HOST REACTION; HEART ATRIUM FIBRILLATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LUNG HEMORRHAGE; MALE; NONHODGKIN LYMPHOMA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SIDE EFFECT; THORAX RADIOGRAPHY; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0345732422     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.6.2400     Document Type: Article

References (12)

1. Robbins RA, Linder J, Stahl MG, et al. Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients. Am J Med 1989; 87:511-518
2. Lewis ID, Defor T, Weisdorf DT. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant 2000; 26:539-543
3. Afessa B, Tefferi A, Litzow MR, et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166:641-645
4. Afessa B, Tefferi A, Litzow MR, et al. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002; 166:1364-1368
5. Hoffman M, Monroe DM III, Roberts HR. Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9:S61-S65
6. Hedner U. Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Dis Mon 2003; 49:39-48
7. Roberts HR. Recombinant factor VIIa (Novoseven) and the safety of treatment. Semin Hematol 2001; 38(4 Suppl 12):48-50
8. Vidarsson B, Onundarson PT. Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Thromb Haemost 2000; 83:634-635
9. Kristensen J, Killander A, Hippe E, et al. Clinical experience with recombinant factor Vila in patients with thrombocytopenia. Haemostasis 1996; 26(suppl 1): 159-164
10. Raptis A, Mavroudis D, Suffredini AF, et al. High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients. Bone Marrow Transplant 1999; 24:879-883
11. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002; 30:975-978
12. Pastores SM, Papadopoulos E, van den Brink M, et al. Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C. Bone Marrow Transplant 2002; 30:131-134